Furthermore, this group showed that the calcineurin inhibitor, tacrolimus, inhibited RANKL expression in RA-FLS by suppressing STAT3, but most importantly SOCS-3 was also induced by tacrolimus. This evidence concerns the gene STAT3 and rheumatoid arthritis.